CTX-M: changing the face of ESBLs in the UK. (Q53851440)

21 May 2018

title

CTX-M: changing the face of ESBLs in the UK. (English)

1 reference

21 May 2018

1

D M Livermore

1 reference

21 May 2018

author name string

P M Hawkey

series ordinal

2

1 reference

21 May 2018

language of work or name

English

0 references

publication date

8 July 2005

1 reference

21 May 2018

Journal of Antimicrobial Chemotherapy

published in

1 reference

21 May 2018

volume

56

1 reference

21 May 2018

issue

3

1 reference

21 May 2018

page(s)

451-454

1 reference

21 May 2018

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Evolution of plasmid-coded resistance to broad-spectrum cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Early dissemination of CTX-M-derived enzymes in South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Prevalence and mechanism of resistance to 'third-generation' cephalosporins in clinically relevant isolates of Enterobacteriaceae from 43 hospitals in the UK, 1990-1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Intra- and inter-generic plasmid-mediated spread of cephalosporin and aminoglycoside resistance amongst Klebsiella aerogenes K41 and other enterobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

An outbreak of a CTX-M-type beta-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Detection of extended-spectrum beta-lactamases in members of the family enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI239

21 January 2018

Identifiers

DOI

10.1093/JAC/DKI239

1 reference

21 May 2018

PubMed ID

16006451

1 reference

21 May 2018